Initial public offering of 6,174,051 equity shares of face value of Rs.10/- each ("equity shares") of Corona Remedies Limited ("company") for cash at a price of Rs.1,062/- per equity share ("offer price") aggregating to Rs.655.37 crores ("offer"), comprising an offer for sale of 1,223,193 equity shares of
face value of Rs.10/- each aggregating to Rs.129.84 crores by Kirtikumar Laxmidas Mehta ("promoter selling sharheolder"), 721,691 equity shares of face value of Rs.10/- each aggregating to Rs.76.61 crores by Minaxi Kirtikumar Mehta, 97,853 equity shares of face value of Rs.10/- each aggregating to Rs.10.39 crores by Dipabahen Niravkumar Mehta, 97,853 equity shares of face value of Rs.10/- each aggregating to Rs.10.39 crores by Brinda Ankur Mehta ("promoter group selling shareholders"), 3,811,613 equity shares of face value of Rs.10/- each aggregating to Rs.404.60 crores by Sepia Investments Limited, 142,488 equity shares of face value of Rs.10/- each aggregating to Rs.15.13 crores by Anchor Partners and 79,360 equity shares of face value of Rs.10/- each aggregating to Rs.8.42 crores by Sage Investment Trust ("investor selling shareholders", and along with the promoter selling shareholder and promoter group selling shareholders, the "selling shareholders") ("offer for sale", and such equity shares offered in the offer for sale, the "offered shares").